Table 8 Comparison of continuous efficacy results for sildenafil, tadalafil, and vardenafil
| Â | Sildenafil (50/100 mg) | Tadalafil (10/20 mg) | Vardenafil (10/20 mg) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Â | Â | Number of | Â | Â | Number of | Â | Â | Number of | Â | |||
Outcome | Dose | Trials | Patients | Weighted mean | Dose | Trials | Patients | Weighted mean | Dose | Trials | Patients | Weighted mean |
Percentage successful attempts | placebo | 16 | 1448 | 23 | placebo | 6 | 388 | 26 | placebo | 7 | 996 | 28 |
| Â | 50/100 | 16 | 1589 | 65 | 10/20 | 6 | 1047 | 62 | 10/20 | 7 | 1789 | 59 |
Erectile function domain score | placebo | 23 | 1870 | 14.0 | placebo | 6 | 388 | 14.6 | placebo | 7 | 996 | 14.0 |
| Â | 50/100 | 23 | 1893 | 22.0 | 10/20 | 6 | 1047 | 22.3 | 10/20 | 7 | 1789 | 20.1 |
EF domain change | placebo | 23 | 1870 | 2.7 | placebo | 7 | 459 | 0.8 | placebo | 7 | 996 | 1.3 |
| Â | 50/100 | 23 | 1893 | 10.1 | 10/20 | 7 | 1192 | 8.4 | 10/20 | 7 | 1344 | 8.3 |